Related references
Note: Only part of the references are listed.Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity
Vittoria Palmieri et al.
MUCOSAL IMMUNOLOGY (2021)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Pulmonary Group 2 Innate Lymphoid Cell Phenotype Is Context Specific: Determining the Effect of Strain, Location, and Stimuli
Lewis J. Entwistle et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-33 deficiency protects mice from DSS-induced experimental colitis by suppressing ILC2 and Th17 cell responses
Xueying Qiu et al.
INFLAMMATION RESEARCH (2020)
ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1-/-Mouse through Promoting M2 Macrophage Polarization
Yong You et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Alyse L. Frisbee et al.
NATURE COMMUNICATIONS (2019)
IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
Michelle A. Williams et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity
Lara Ravanetti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion
Amanda Waddell et al.
JOURNAL OF IMMUNOLOGY (2019)
IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3
Pingping Zhu et al.
NATURE IMMUNOLOGY (2019)
Colorectal Cancer in Inflammatory Bowel Disease
Ryan W. Stidham et al.
CLINICS IN COLON AND RECTAL SURGERY (2018)
Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization
Zhengxiang He et al.
CYTOKINE (2018)
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Loris R. Lopetuso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response
Jun-feng Zhu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population
Daniele C. Nascimento et al.
NATURE COMMUNICATIONS (2017)
IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis
Lei Tu et al.
ONCOTARGET (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-33 and the intestine: The good, the bad, and the inflammatory
Zerina Hodzic et al.
CYTOKINE (2017)
Role of regulatory T cell in the pathogenesis of inflammatory bowel disease
Akiko Yamada et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function
Amanda Waddell et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses
Junfeng Zhu et al.
MEDIATORS OF INFLAMMATION (2015)
IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions
Laurel A. Monticelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells
Benjamin M. Matta et al.
JOURNAL OF IMMUNOLOGY (2014)
Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
Tiago Nunes et al.
MEDIATORS OF INFLAMMATION (2014)
Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in mice
An-Jiang Wang et al.
CELL AND BIOSCIENCE (2014)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
Type 2 innate lymphoid cells control eosinophil homeostasis
Jesse C. Nussbaum et al.
NATURE (2013)
Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13
Ana Camelo et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice
Lihua Duan et al.
MOLECULAR MEDICINE (2012)
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Janice J. Kim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Therapy with anti-TNF alpha Antibody Enhances Number and Function of Foxp(3+) Regulatory T Cells in Inflammatory Bowel Diseases
Gilles Boschetti et al.
INFLAMMATORY BOWEL DISEASES (2011)
IL-33 is upregulated in colonocytes of ulcerative colitis
Jakob Benedict Seidelin et al.
IMMUNOLOGY LETTERS (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Foxp3(+) Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease
Nicola Eastaff-Leung et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Jose C. Alves-Filho et al.
NATURE MEDICINE (2010)
Systemically dispersed innate IL-13-expressing cells in type 2 immunity
April E. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Damo Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses
MJ Townsend et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice
L Stevceva et al.
GENES AND IMMUNITY (2000)
Share Paper
